Assuming study is required, the following results were found.

  • Multiple sclerosis drug slows brain shrinkage, study finds

    progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were gastrointestinal and headaches. The study was supported by the...

    https://mschristian.org/index.php/articles/2-uncategorised/4405-multiple-sclerosis-drug-slows-brain-shrinkage-study-finds
  • Novartis receives positive CHMP opinion for Mayzent® (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS) | Small Molecules | News Channels - PipelineReview.com

    multiple sclerosis (SPMS) in Europe[1]) CHMP opinion is based on the Phase III EXPAND trial, the largest randomized clinical study in a broad SPMS patient population (EDSS score 3.0 to 6.5 at baseline), showing Mayzent significantly reduced the risk of...

    https://mschristian.org/index.php/articles/2-uncategorised/9270-novartis-receives-positive-chmp-opinion-for-mayzent-siponimod-for-the-treatment-of-adult-patients-with-active-secondary-progressive-multiple-sclerosis-spms-small-molecules-news-channels-pipelinereview-com
  • Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study

    disability, cognition and inflammatory markers. However, clinical evidence on these diets is scarce. In the clinical study protocol presented here, we investigate whether a KD and a FD are superior to a standard diet (SD) in terms of therapeutic effects...

    https://mschristian.org/index.php/articles/2-uncategorised/9976-ketogenic-diet-and-fasting-diet-as-nutritional-approaches-in-multiple-sclerosis-nams-protocol-of-a-randomized-controlled-study
  • Does sunlight change our gut microbiome?

    team of researchers, many from the University of British Columbia, in Vancouver, Canada, set out to answer this question by studying how the gut microbiome responds to UV light. When volunteers who were deficient in vitamin D received three sessions of...

    https://mschristian.org/index.php/articles/2-uncategorised/9056-does-sunlight-change-our-gut-microbiome
  • Weekend Warriors Be Warned: Irregular Sleep Patterns Linked to CV Risk

    variable a person's sleep schedule, the greater his or her risk of cardiovascular disease (CVD), data from the Multi-Ethnic Study of Atherosclerosis (MESA) showed. A larger range in individual sleep duration and sleep timing across 7 days of wrist...

    https://mschristian.org/index.php/blog/weekend-warriors-be-warned-irregular-sleep-patterns-linked-to-cv-risk
  • Does sunlight change our gut microbiome?

    team of researchers, many from the University of British Columbia, in Vancouver, Canada, set out to answer this question by studying how the gut microbiome responds to UV light. When volunteers who were deficient in vitamin D received three sessions of...

    https://mschristian.org/index.php/blog/does-sunlight-change-our-gut-microbiome
  • Study investigates link between social cognition and fatigue, mood in multiple sclerosis

    Reviewed by Kate Anderton, B.Sc. (Editor)Aug 29 2019 A recent study by Kessler Foundation researchers linked the deficits in social cognition in multiple sclerosis with symptoms in other domains. The article, "Relationship between social cognition and...

    https://mschristian.org/index.php/articles/2-uncategorised/8406-study-investigates-link-between-social-cognition-and-fatigue-mood-in-multiple-sclerosis
  • Genentech’s Satralizumab Significantly Reduced Relapse Risk in Second Positive Phase III Study for Neuromyelitis Optica Spectrum Disorder

    Pivotal Phase III SAkuraStar study shows 55% reduction in the risk of relapse for satralizumab monotherapy versus placebo presented at ECTRIMS Congress 2019 74% reduction in the risk of relapse for satralizumab monotherapy versus placebo in people with...

    https://mschristian.org/index.php/articles/2-uncategorised/8612-genentech-s-satralizumab-significantly-reduced-relapse-risk-in-second-positive-phase-iii-study-for-neuromyelitis-optica-spectrum-disorder
  • Multiple sclerosis treatments delay progression of the disease

    An international study finds multiple sclerosis treatments have long-term benefits, and that early treatment is important. The Royal Melbourne Hospital and University of Melbourne-led study is the first to provide evidence that the currently available...

    https://mschristian.org/index.php/blog/multiple-sclerosis-treatments-delay-progression-of-the-disease
  • First-in-kind Human 3-dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station - Business Wire

    teams from Aspen Neuroscience and the New York Stem Cell Foundation (NYSCF) Research Institute will send a first-in-kind study of neurodegenerative disease to the International Space Station (ISS) on the nineteenth SpaceX Commercial Resupply Services...

    https://mschristian.org/index.php/blog/first-in-kind-human-3-dimensional-models-of-parkinson-s-disease-and-progressive-multiple-sclerosis-launching-to-the-international-space-station-business-wire
  • Could medical marijuana help older people with their ailments?

    lateral sclerosis, Parkinson's disease, neuropathy, spinal cord damage and multiple sclerosis, according to a preliminary study released today that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4 to...

    https://mschristian.org/index.php/blog/could-medical-marijuana-help-older-people-with-their-ailments
  • Common treatment for multiple sclerosis may prolong life

    have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients. The study, published today in the journal Brain, found that people with MS who took a beta interferon drug had a 32 per cent lower...

    https://mschristian.org/index.php/blog/common-treatment-for-multiple-sclerosis-may-prolong-life
  • Study finds that many people diagnosed with MS do not have the condition

    in walking. MS and migraine attacks also have some symptoms in common, including dizziness and vision impairment. A recent study pooled data on people who had received a wrong diagnosis of MS and found that 72 of the 110 patients had other conditions,...

    https://mschristian.org/index.php/articles/2-uncategorised/8714-study-finds-that-many-people-diagnosed-with-ms-do-not-have-the-condition-1
  • Mindfulness training may be helpful in more than one way for people with MS

    they also improved compared to those who tried another treatment, called adaptive cognitive training. This was a small pilot study, so we need to replicate the results, but these findings were very encouraging. It is exciting to find a treatment that...

    https://mschristian.org/index.php/mindfulness-training-may-be-helpful-in-more-than-one-way-for-people-with-ms
  • CMSC INforMS: Use of DMTs Changing ‘Natural History’ of Relapsing MS, Study Says

    to disability since the introduction of disease-modifying treatments (DMTs) some 20 years ago, according to a retrospective study. The study, “Outcomes in a Modern Cohort of Treated Multiple Sclerosis Patients Followed from Diagnosis Up to 15 Years,”...

    https://mschristian.org/index.php/articles/2-uncategorised/9867-cmsc-informs-use-of-dmts-changing-natural-history-of-relapsing-ms-study-says
  • Multiple sclerosis treatments delay progression of the disease

    An international study finds multiple sclerosis treatments have long-term benefits, and that early treatment is important. The Royal Melbourne Hospital and University of Melbourne-led study is the first to provide evidence that the currently available...

    https://mschristian.org/index.php/articles/2-uncategorised/5282-multiple-sclerosis-treatments-delay-progression-of-the-disease
  • Study: Daily Low-Dose Aspirin Did Not Reduce Dementia Risk in the Elderly

    Today) -- Study Authors: Joanne Ryan, Elsdon Storey, et al.; David S. Knopman, Ronald C. Petersen Target Audience and Goal Statement: Neurologists The goal of this study was to assess the effect of low-dose aspirin versus placebo on... Original link

    https://mschristian.org/index.php/articles/2-uncategorised/10547-study-daily-low-dose-aspirin-did-not-reduce-dementia-risk-in-the-elderly
  • Syracuse has highest rate of multiple sclerosis in US, study shows - syracuse.com

    SYRACUSE, NY – Syracuse has the nation’s highest rate of multiple sclerosis, according to a new study. An analysis of medical claims by the Blue Cross Blue Shield Association found the multiple diagnosis rate in Syracuse in 2017 was 45 per 10,000...

    https://mschristian.org/index.php/articles/2-uncategorised/8850-syracuse-has-highest-rate-of-multiple-sclerosis-in-us-study-shows-syracuse-com
  • Study sheds light on brain cell changes in people with MS

    cells found in the brains of people with multiple sclerosis could help develop improved therapies, research has found. The study focused on cells in the brain that help to repair damage to nerve cells caused by the disease. Researchers identified...

    https://mschristian.org/index.php/blog/study-sheds-light-on-brain-cell-changes-in-people-with-ms
  • Community Wellness Study for people affected by MS

    PLENTY of spots available in the study. This is a 5 year study and our recruitment goal is 600 participants, and we have recruited ~170 participants so far (this is the Year 1 of the study). Main Eligibility Criteria: Telephone-based health/wellness...

    https://mschristian.org/index.php/blog/community-wellness-study-for-people-affected-by-ms

Results 21 - 40 of 480